Abstract

A 25-year-old Caucasian flight attendant with an extensive travel history presented with night sweats, fevers, weight loss and axillary and supraclavicular lymphadenopathy. Apart from surgical breast augmentation, she had no past medical or surgical history. She was anaemic, leucopenic and lymphopenic, and a broad infection screen was negative. Cross-sectional imaging revealed ipsilateral silicone breast implant rupture, with leaking of implant contents into the surrounding tissue. Histological examination of an axillary lymph node core biopsy confirmed the diagnosis of silicone
lymphadenopathy.

This case illustrates the broad differential for acute painful lymphadenopathy in the context of global travel, and the use of targeted infection testing, early cross-sectional imaging and biopsy to arrive at an unexpected diagnosis.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Chau I, Kelleher MT, Cunningham D, et al; Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer 2003; 88(3): 354–61.
2. Gaddey HL, Riegel AM; Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician 2016; 94(11): 896–903.
3. Zambacos GJ, Molnar C, Mandrekas AD; Silicone lymphadenopathy after breast augmentation: case reports, review of the literature, and current thoughts. Aesthetic Plast Surg. 2013; 37(2): 278–89.
4. Brown SL, Silverman BG, Berg WA; Rupture of silicone-gel breast implants: causes, sequelae, and diagnosis. Lancet. 1997; 350(9090): 1531–7.
5. Brown SL, Middleton MS, Berg WA, et al; Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. AJR Am J Roentgenol. 2000; 175(4): 1057–64.
6. Leckenby J, Chana J, Harrison D, et al; Poly Implant Prothèse™ (PIP) experience in the United Kingdom: A prospective cohort study into the accuracy of diagnostic imaging findings in comparison to operative findings of 1029 implants. J Plast Reconstr Aesthet Surg. 2016; 69(4): 446–51.
7. Kim B, Roth C, Chung KC, et al; Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg. 2011; 127(6): 2141–50.
8. Deapen DM, Brody GS; Augmentation mammaplasty and breast cancer: a 5-year update of the Los Angeles study. Plast Reconstr Surg. 1992; 89(4): 660–5.
9. Maijers MC1, Niessen FB, Veldhuizen JF, et al; MRI screening for silicone breast implant rupture: accuracy, inter- and intraobserver variability using explantation results as reference standard. Eur Radiol. 2014; 24(6): 1167–75.
10. Hennekens CH1, Lee IM, Cook NR, et al; Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA. 1996; 275(8): 616–21.
11. Janowsky EC, Kupper LL, Hulka BS; Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000; 342(11): 781–90.
12. Ho J; An unusual case of Fever and lymphadenopathy. Acute Med. 2009; 8(2): 73–4.
13. Blum A, Abboud W, Shajrawi I, et al; Prolonged fever due to silicone granulomatosis. Isr Med Assoc J. 2007; 9(2): 121–2.
14. Lovich SF, Meland NB; Breast implants and air flight. Plast Reconstr Surg. 1990; 86(1): 172.
15. Bachman JJ; Boyle’s law and breast implants. N Engl J Med. 1994;331(7): 483–4.
16. Brown MA, Nevrekar D, Faino AV, et al; Periimplant Breast Gas at High Altitudes: Prevalence, Significance, and Possible Associated Factors. AJR Am J Roentgenol. 2015; 205(5): 971–5.